A Safety, Tolerability and Efficacy Study of V158866 in Central Neuropathic Pain Following Spinal Cord Injury

Exclusion Criteria

• •women of child-bearing potential
• •men who intend to father a child
• •a history of multiple drug allergies, hypersensitivity to any cannabinoid
• •an increased risk of seizure
• •evidence of depression and/or a score of \>19 on the BDI-II
• •suicidal ideation or suicidal behavior in the past 10 years
• •a history of substance abuse or dependence within the past year, excluding nicotine and caffeine
• •a positive urine test for cannabis at screening
• •taking excluded medications that cannot be stopped
• •a positive pregnancy test